About
NH TherAguix develops targeted cancer treatments using nanotechnology to deliver therapeutic agents directly to tumors, enhancing efficacy and reducing side effects.
Explore NH TherAguix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.